You are using an outdated browser. Please upgrade your browser to improve your experience.
Become a Fellow
ACP offers a number of resources to help members make sense of the MOC requirements and earn points.
Understanding MOC Requirements
Earn MOC points
The most comprehensive meeting in Internal Medicine.
April 11-13, 2019
Internal Medicine Meeting 2019
Prepare for the Certification and Maintenance of Certification (MOC)
Exam with an ACP review course.
Board Certification Review Courses
MOC Exam Prep Courses
Treating a patient? Researching a topic? Get answers now.
Visit AnnalsLearn More
Visit MKSAP 18Learn More
Visit DynaMed Plus
Ensure payment and avoid policy violations. Plus, new resources to help you navigate the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Access helpful forms developed by a variety of sources for patient charts, logs, information sheets, office signs, and use by practice administration.
ACP advocates on behalf on internists and their patients on a number of timely issues. Learn about where ACP stands on the following areas:
© Copyright 2018 American College of Physicians. All Rights Reserved. 190 North Independence Mall West, Philadelphia, PA 19106-1572
Toll Free: (800) 523.1546 · Local: (215) 351.2400
Sent: Monday, September 22, 2014
Today's CMA Alert is an article on the implementation of SB 866
(Hernandez - 2011). The new law is intended to streamline and
standardize the prior authorization process for prescription drugs.
It will require all insurers, health plans (and their contracting
medical groups/IPAs) and providers to use a standardized two-page
form for prior authorizations of prescription medications.
The law also requires plans and insurers to make a determination
on prescription drug prior authorization requests within two days
of receipt, and if they fail to do so the requests will be deemed
authorized. Currently, payors are allowed five business days to
approve a prior auth for prescription drugs. The new law does not
expand the list of medications that require a prior
Unfortunately, the DMHC and DOI are implementing on different
dates. To prevent unnecessary rejections, duplicative
administrative work and delays in patient access to necessary
mediations, it is important that practices are aware of the new
requirement, which products are affected and when.
You can review the article
online. The article also includes a link to a new members' only
resource titled, "A
Physician's Guide to Implementation of SB 866: The new standardized
prescription drug prior authorization form," which includes a
Q&A on the topic.
Senior Director, CMA
1201 J St. #200
Sacramento , CA 95814